Trial
NCT02313012
Safety and PK Study of CC-90003 in Relapsed/Refractory Solid Tumors
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Celgene
Collaborators
—
Condition
Neoplasm Metastasis
Intervention
CC-90003
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-11-18